Consolidated Balance Sheets (USD $)	Mar. 31, 2012	Dec. 31, 2011
Current assets
Cash and cash equivalents	$ 16,492	$ 7,187
Prepaid expenses and other current assets	420,682	26,820
Total current assets	437,174	34,007
Property and equipment, net of accumulated depreciation of $10,395
Total Assets	437,174	34,007
Liabilities and Shareholders' Equity
Accounts payable	827,365	811,486
Accrued expenses and interest	456,645	283,185
Accrued consulting fees - share based	8,000
Accrued compensation	249,480	1,445,249
Current portion of convertible notes payable	415,000	415,000
Derivative liabilities	1,225,847	1,491
Notes payable - current	2,532,001	2,543,788
Total current liabilities	5,714,337	5,500,199
Accrued interest-non current	67,765	16,515
Notes payable - non-current	2,428,731	2,420,855
Convertible notes payable – non-current, net of $52,504 and $60,380 of unamortized discount, respectively	2,428,731	2,420,855
Total liabilities	8,375,833	7,937,569
Preferred stock, par value $.001 per share, 10,000,000 shares authorized, no shares issued and outstanding at March 31, 2012 and December 31, 2011
Common stock, par value $.001 per share, 100,000,000 shares authorized, 79,558,599 and 46,636,849 issued and outstanding at March 31,2012 and December 31, 2011, respectively	79,559	46,637
Additional paid-in capital	7,253,358	5,773,505
Deficit accumulated during the development stage	(15,271,659)	(13,723,704)
Total shareholders' deficit	(7,938,659)	(7,903,562)
Total Liabilities and Shareholders' Deficit	$ 437,174	$ 34,007